Registration of patients with thyroid cancer
Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic
This study is collecting information on adults with different types of thyroid cancer to better understand their experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Grupo Espanol de Tumores Neuroendocrinos Academic / other |
| Locations | 1 site (Barcelona) |
| Trial ID | NCT03765333 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect epidemiological data on patients aged 18 and older who have been diagnosed with primary thyroid cancer. It will involve multiple centers and will focus on patients with differentiated, medullary, or anaplastic thyroid cancer confirmed by histopathology. The study will gather retrospective data from oncology services to better understand the characteristics and outcomes of these patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed diagnosis of differentiated, medullary, or anaplastic thyroid cancer.
Not a fit: Patients under 18 years of age or those with unconfirmed or different types of thyroid cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of thyroid cancer and improve patient management strategies.
How similar studies have performed: Other observational studies in oncology have shown success in collecting valuable data, making this approach well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology. * Patients who agree to participate and are able to understand the information sheet and sign the informed consent Exclusion Criteria: * Patients under 18 years of age. * Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed. * Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.
Where this trial is running
Barcelona
- Hospital Universitari Vall d'Hebron — Barcelona, Spain (Recruiting)
Study contacts
- Study coordinator: Secretaria Técnica GETNE
- Email: getne@mfar.net
- Phone: +34 93 434 44 12
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.